MRNA

Moderna (MRNA) Stock Price

Closed
MRNA
$199.30
+$1.24(+0.62%)

Content updated: 2026-11-22 22:41:59

Yesterday's Close
$198.06
Today's Open
$197.58
Today's High
$210.00
Today's Low
$191.50
Volume
8.41M shares
52-Week Range
$23.92-$280.80

As of 2026-11-22 22:41:59, Moderna (MRNA) was quoted at $199.30, a change of +$1.24 (+0.62%) from the previous close. The day's range was $191.50–$210.00, and the 52-week range was $23.92–$280.80.

Why Is Moderna (MRNA) Stock Rising?

AI Stock Price Analysis

Content updated: 2026-11-20 20:43:57

Shares climbed to an intraday high of $210 before fading to $195.33 at the snapshot, down 1.93% from the prior close and below the $201.95 volume-weighted average price (VWAP), a clear high-pullback structure. Discussion has centered on late-stage data for the personalized melanoma vaccine partnered with Merck and on cash spending as oncology investment rises.

Past 1W-10.18%Period Low $189.98Period High $222.42
Past 1M-18.74%Period Low $179.53Period High $280.80
Past 3M+36.73%Period Low $130.00Period High $280.80
Past 1Y+771.46%Period Low $22.28Period High $280.80

About Moderna (MRNA)

Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses like COVID-19, influenza, and respiratory syncytial virus (RSV); latent viral infections such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), herpes simplex virus (HSV), and varicella-zoster virus (VZV); and public health threats like Zika and Nipah. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions. Moderna maintains strategic alliances with several prominent entities, including AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, Carisma Therapeutics, Inc., Metagenomi, Inc., the Defense Advanced Research Projects Agency (DARPA), the Biomedical Advanced Research and Development Authority (BARDA), the Institute for Life Changing Medicines, and The Bill & Melinda Gates Foundation. It also holds a collaboration and license agreement with Chiesi Farmaceutici S.P.A. Founded in 2010 as Moderna Therapeutics, Inc., the company officially became Moderna, Inc. in August 2018. Its corporate headquarters are located in Cambridge, Massachusetts.
Ticker / Exchanges
MRNA / NASDAQ
Industry / Sector
Biotechnology / Healthcare
CEO
Stéphane Bancel
Headquarters
Cambridge,MA,US
Listing Date
2018-12-07

Recent Company Events

  • 2027-02-12
    Earnings Report · ExpectedOn 2027-02-12, the 2026/Q4 earnings report is expected to be released.

Moderna (MRNA) Derivatives Trading

MRNATrade
Stocks

Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.

MRNATrade
CFD

Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.

MRNAUSDTTrade
Perpetual Futures

Contracts based on stock prices, with no expiration date. They support 24/7 long, short, and leveraged trading without holding the underlying shares. Be aware of funding fees and liquidation risk.

Moderna (MRNA) Company Financials

Valuation and Shares

Market Cap
$78.94B
P/E Ratio (TTM)
-27.69
P/B Ratio
11.54
Shares Outstanding
404.62M shares
Float Shares
372.25M shares
Dividend Yield (TTM)
0.00%

Latest Reported Financials

2026 Q3 Financials

Report Release Date: 2026-11-06

Operating Revenue (Actual)

$1.31B

Same Period Last Year: +29.23%

Earnings per Share (Actual)

$0.38

Same Period Last Year: +174.51%

Financials · Actuals

Actual Value2022/Annual2023/Annual2024/Annual2025/Annual
Revenue$19.26B$6.84B$3.23B$1.94B
Net Profit$8.36B-$4.71B-$3.56B-$2.82B
Operating Cash Flow$4.98B-$3.11B-$3.00B-$1.87B

Learn

MRNA FAQ

What is the current stock price of Moderna (MRNA)?

x
As of 2026-11-22 22:41 (UTC+8), the latest available quote for Moderna (MRNA) is $199.30 USD, with a change of +$1.24 USD (+0.62%) from the previous trading day's close. Current market status: Closed.

Which exchange is MRNA listed on?

x

How has Moderna stock performed over the past month?

x

What is the market cap of Moderna?

x

What are Moderna's latest financial results?

x

What factors may affect the stock price of Moderna (MRNA)?

x

Other Trading Markets

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.